The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
MELD accurately predicts mortality in patients with alcoholic hepatitis†
Abstract
Assessing severity of disease in patients with alcoholic hepatitis (AH) is useful for predicting mortality, guiding treatment decisions, and stratifying patients for therapeutic trials. The traditional disease-specific prognostic model used for this purpose is the Maddrey discriminant function (DF). The model for end-stage liver disease (MELD) is a more recently developed scoring system that has been validated as an independent predictor of patient survival in candidates for liver transplantation. The aim of the present study was to examine the ability of MELD to predict mortality in patients with AH. A retrospective cohort study of 73 patients diagnosed with AH between 1995 and 2001 was performed at the Mayo Clinic in Rochester, Minnesota. MELD was the only independent predictor of mortality in patients with AH. MELD was comparable to DF in predicting 30-day mortality (c-statistic and 95% CI: 0.83 [0.71-0.96] and 0.74 [0.62-0.87] for MELD and DF, respectively, not significant) and 90-day mortality (c-statistic and 95% CI: 0.86 [0.77-0.96] and 0.83 [0.74-0.92] for MELD and DF, respectively, not significant). A MELD score of 21 had a sensitivity of 75% and a specificity of 75% in predicting 90-day mortality in AH. In conclusion, MELD is useful for predicting 30-day and 90-day mortality in patients with AH and maintains some practical and statistical advantages over DF in predicting mortality rate in these patients. MELD is a useful clinical tool for gauging mortality and guiding treatment decisions in patients with AH, particularly those complicated by ascites and/or encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Self-citationMalinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Self-citationModel for end-stage liver disease (MELD) and allocation of donor livers
Wiesner, R., Edwards, E., Freeman, R., Harper, A., Kim, R., Kamath, P., Kremers, W., Lake, J., Howard, T., Merion, R. M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50016 · Cited by 2,528
Self-citationCorticosteroid therapy of alcoholic hepatitis
Maddrey, W. C., Boitnott, J. K., Bedine, M. S., Weber, F. L., Mezey, E., & White, R. I. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90401-8 · Cited by 925
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
Self-citationAkriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Carithers, R. L., Herlong, H. F., Diehl, A. M., Shaw, E. W., Combes, B., Fallon, H. J., & Maddrey, W. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-9-685 · Cited by 504
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease
SAID, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.010 · Cited by 437
A Randomized Trial of Prednisolone in Patients with Severe Alcoholic Hepatitis
Ramond, M.-J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J.-C., & Benhamou, J.-P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260802 · Cited by 392
Mathurin, P., Mendenhall, C. L., Carithers, R. L., Ramond, M.-J., Maddrey, W. C., Garstide, P., Rueff, B., Naveau, S., Chaput, J.-C., & Poynard, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00289-6 · Cited by 353
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology
McCullough, A. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00468-7 · Cited by 271
Mendenhall, C. L., Anderson, S., Garcia-Pont, P., Goldberg, S., Kiernan, T., Seeff, L. B., Sorrell, M., Tamburro, C., Weesner, R., Zetterman, R., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412063112302 · Cited by 267
Imperiale, T. F., & McCullough, A. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-299 · Cited by 232
Mathurin, P., Abdelnour, M., Ramond, M.-J., Carbonell, N., Fartoux, L., Serfaty, L., Valla, D., Poupon, R., Chaput, J.-C., & Naveau, S. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.038 · Cited by 220
Sheth, M., Riggs, M., & Patel, T. (2002) · BMC Gastroenterology · doi:10.1186/1471-230x-2-2 · Cited by 191
Orrego, H., Israel, Y., Blake, J. E., & Medline, A. (1983) · Hepatology · doi:10.1002/hep.1840030602 · Cited by 189
Pathogenesis, Diagnosis, and Treatment of Alcoholic Liver Disease
Menon, K. V., Gores, G. J., & Shah, V. H. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.10.1021 · Cited by 149
Self-citationA Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis
Menon, K. V. N., Stadheim, L. M., Kamath, P. S., Wiesner, R. H., Gores, G. J., Peine, C. J., & Shah, V. H. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04034.x · Cited by 127
Self-citationDoes This Patient Have Ascites?
Williams, J. W. (1992) · JAMA · doi:10.1001/jama.1992.03480190087038 · Cited by 83
Williams, J. W. (1992) · JAMA · doi:10.1001/jama.267.19.2645 · Cited by 59
Is the change in MELD score a better indicator of mortality than baseline MELD score?
Kamath, P. S., & Kim, W. R. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50031 · Cited by 36
Self-citationPentoxifylline and alcoholic hepatitis
Morgan, T. R. M., & McClain, C. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.20826 · Cited by 23
Cited by
The model for end-stage liver disease (MELD)
Kamath, P. S., & Kim, R. W. (2007) · Hepatology · doi:10.1002/hep.21563 · Cited by 1,674
Self-citationSeitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
Early Liver Transplantation for Severe Alcoholic Hepatitis
Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F., Castel, H., Duhamel, A., Pageaux, G.-P., Leroy, V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105703 · Cited by 960
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
Metadata
- Authors
- Dunn, W., Jamil, L. H., Brown, L. S., Wiesner, R. H., Kim, W. R., Menon, K. V. N., Malinchoc, M., Kamath, P. S., & Shah, V.
- Venue
- Hepatology
- Published
- 2005-02
- Volume
- 41
- Issue
- 2
- Pages
- 353-358
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2073048831
- Cited by
- 530
- References
- 23
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.